Dr. Jagan Pillai Principal Investigator and CADRC Director
Welcome, and thank you for your interest in the Cleveland Alzheimer’s Disease Research Center (CADRC).
Whether you are a caregiver, researcher, or someone who has been diagnosed with Alzheimer’s disease or a related dementia (AD/ADRD), the CADRC is for you.
The CADRC is one of 38 NIH-supported Alzheimer’s Disease Research Centers (ADRCs) in the country, all working together to prevent and effectively treat AD/ADRD. Since its founding in 2019, the CADRC has been working assiduously to address local and national AD/ADRD needs and to chart a future without these conditions.
By bringing together the talents and resources of Cleveland’s leading institutions—Case Western Reserve University, Cleveland Clinic, University Hospitals, MetroHealth, and the Veterans Affairs Northeast Ohio Health Care System—and ongoing collaborations with regional partners Kent State University, Cleveland State University, and Northeast Ohio Medical University, we have built a strong foundation for discovery, innovation, and care.
Alzheimer’s disease and related dementias affect about 1 in 9 people in the U.S. and over 1 in 10 in Ohio aged 65 and older, or about 6.9 million people. The number of individuals living with AD/ADRD is expected to grow further as the population ages.
Recognizing this public health challenge, the CADRC has set ambitious goals to meet the growing needs of our community in the fight against AD/ADRD.
The CADRC’s notable partnership with the VA and its unusually large Dementia with Lewy Bodies cohort uniquely positions it to uncover factors driving disease progression. This work will improve prediction, diagnosis, and therapeutic development for a highly understudied and clinically challenging dementia and for less-studied populations.
You are an essential partner in making these goals a reality. With your partnership—through joining our research cohort, advocating for AD/ADRD research, and engaging with the CADRC—we can continue Cleveland’s proud tradition of medical innovation and excellence by advancing research, improving care, and bringing hope to those affected by dementia and their caregivers.
We invite you to inquire about our mission, research, outreach, or collaborative opportunities. Stay connected with us through social media and/or our quarterly newsletter for updates on Cleveland’s and the nation’s latest AD/ADRD research developments.
Thank you for joining us in making a difference for generations to come.
Welcome, and thank you for your interest in the Cleveland Alzheimer’s Disease Research Center (CADRC).
Whether you are a caregiver, researcher, or someone who has been diagnosed with Alzheimer’s disease or a related dementia (AD/ADRD), the CADRC is for you.
The CADRC is one of 38 NIH-supported Alzheimer’s Disease Research Centers (ADRCs) in the country, all working together to prevent and effectively treat AD/ADRD. Since its founding in 2019, the CADRC has been working assiduously to address local and national AD/ADRD needs and to chart a future without these conditions.
By bringing together the talents and resources of Cleveland’s leading institutions—Case Western Reserve University, Cleveland Clinic, University Hospitals, MetroHealth, and the Veterans Affairs Northeast Ohio Health Care System—and ongoing collaborations with regional partners Kent State University, Cleveland State University, and Northeast Ohio Medical University, we have built a strong foundation for discovery, innovation, and care.
Alzheimer’s disease and related dementias affect about 1 in 9 people in the U.S. and over 1 in 10 in Ohio aged 65 and older, or about 6.9 million people. The number of individuals living with AD/ADRD is expected to grow further as the population ages.
Recognizing this public health challenge, the CADRC has set ambitious goals to meet the growing needs of our community in the fight against AD/ADRD.
The CADRC’s notable partnership with the VA and its unusually large Dementia with Lewy Bodies cohort uniquely positions it to uncover factors driving disease progression. This work will improve prediction, diagnosis, and therapeutic development for a highly understudied and clinically challenging dementia and for less-studied populations.
You are an essential partner in making these goals a reality. With your partnership—through joining our research cohort, advocating for AD/ADRD research, and engaging with the CADRC—we can continue Cleveland’s proud tradition of medical innovation and excellence by advancing research, improving care, and bringing hope to those affected by dementia and their caregivers.
We invite you to inquire about our mission, research, outreach, or collaborative opportunities. Stay connected with us through social media and/or our quarterly newsletter for updates on Cleveland’s and the nation’s latest AD/ADRD research developments.
Thank you for joining us in making a difference for generations to come.
Dr. Jagan Pillai Principle Investigator and CADRC Director
